- Home
- ANIP vs TRMD Comparison
ANIP vs TRMD Comparison
Compare ANIP & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- TRMD
- Stock Information
- Founded
- ANIP 2001
- TRMD 1889
- Country
- ANIP United States
- TRMD United Kingdom
- Employees
- ANIP N/A
- TRMD N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- TRMD Marine Transportation
- Sector
- ANIP Health Care
- TRMD Consumer Discretionary
- Exchange
- ANIP Nasdaq
- TRMD Nasdaq
- Market Cap
- ANIP 2.0B
- TRMD 2.1B
- IPO Year
- ANIP N/A
- TRMD N/A
- Fundamental
- Price
- ANIP $98.30
- TRMD $22.53
- Analyst Decision
- ANIP Strong Buy
- TRMD Buy
- Analyst Count
- ANIP 9
- TRMD 1
- Target Price
- ANIP $86.00
- TRMD $23.00
- AVG Volume (30 Days)
- ANIP 488.4K
- TRMD 882.3K
- Earning Date
- ANIP 11-07-2025
- TRMD 11-06-2025
- Dividend Yield
- ANIP N/A
- TRMD 11.80%
- EPS Growth
- ANIP N/A
- TRMD N/A
- EPS
- ANIP N/A
- TRMD 3.31
- Revenue
- ANIP $747,399,000.00
- TRMD $1,321,800,000.00
- Revenue This Year
- ANIP $39.32
- TRMD N/A
- Revenue Next Year
- ANIP $9.62
- TRMD N/A
- P/E Ratio
- ANIP N/A
- TRMD $6.66
- Revenue Growth
- ANIP 38.68
- TRMD N/A
- 52 Week Low
- ANIP $52.50
- TRMD $13.60
- 52 Week High
- ANIP $99.50
- TRMD $36.78
- Technical
- Relative Strength Index (RSI)
- ANIP 77.93
- TRMD 61.91
- Support Level
- ANIP $96.50
- TRMD $21.81
- Resistance Level
- ANIP $99.50
- TRMD $23.65
- Average True Range (ATR)
- ANIP 2.17
- TRMD 0.55
- MACD
- ANIP -0.33
- TRMD -0.03
- Stochastic Oscillator
- ANIP 87.17
- TRMD 66.07
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.